Adcendo

Drug Discovery · Frederiksberg, Denmark · Founded 2017 · Privately Held (backing)

Developer of antibody-drug conjugates designed to create new medicines for cancer patients with significant unmet needs. Adcendo is based in Frederiksberg, Denmark and was founded in 2017. It was valued at $210 million at its later-stage round in Nov 2024, the last priced event on record. It has raised $316 million across 2 recorded rounds; the latest was a $134 million Series B in Nov 2024.

PMV mark · valuation
$209.9M
Oct 2026
Priced at
its later-stage round
Nov 2024
Total raised
$315.9M
Last round
Later Stage VC (Series B)
Nov 2024
How much has Adcendo raised?
$315.9Macross 2 recorded rounds · Apr 2023 – Nov 2024

Most recently, Adcendo raised $134.1M in its Later Stage VC (Series B) (Nov 2024).

Free account
More of Adcendo with a free account
  • ·The complete investor list: 21 names
  • ·Watch Adcendo: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Adcendo round by round

2 rounds
Nov 2024Later Stage VC (Series B)$134.1M▮
+ 1 more investors · free account
Apr 2023Later Stage VC (Series A)$105.2M▮
+ 1 more investors · free account

How much has Adcendo raised?

Adcendo has raised $316 million in total; 2 of its rounds are on record. The largest on record was a $134 million Series B in Nov 2024.

Adcendo investors

21 investors are on record for Adcendo, including Bpifrance, RA Capital Management, OrbiMed and InnoFounder. The Series B in Nov 2024 drew 11 investors.

For fundraisers
Raising for a company like Adcendo?

21 investors have backed Adcendo — start your target list with the firms already writing checks in drug discovery.

See all 21 investors →

Frequently asked about Adcendo

How much has Adcendo raised?
Adcendo has raised $315.9M in total across 2 recorded funding rounds.
When was Adcendo's last funding round?
Adcendo's most recent recorded round was Later Stage VC (Series B) in Nov 2024, raising $134.1M.